PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review

Title
PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review
Authors
Keywords
PD-L1, Checkpoint inhibitors, Advanced NSCLC, Immunohistochemistry, Assay, Prognosis
Journal
LUNG CANCER
Volume 112, Issue -, Pages 200-215
Publisher
Elsevier BV
Online
2017-08-10
DOI
10.1016/j.lungcan.2017.08.005

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now